UK markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
54.300+3.650 (+7.21%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 220.03B
Enterprise value 212.11B
Trailing P/E 58.28
Forward P/E 42.55
PEG ratio (5-yr expected) 1.42
Price/sales (ttm)19.28
Price/book (mrq)5.86
Enterprise value/revenue 20.61
Enterprise value/EBITDA 46.99

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 3-55.23%
S&P500 52-week change 3-1.04%
52-week high 3148.000
52-week low 340.300
50-day moving average 357.649
200-day moving average 387.216

Share statistics

Avg vol (3-month) 329.19M
Avg vol (10-day) 318.66M
Shares outstanding 54.22B
Implied shares outstanding 6N/A
Float 83.56B
% held by insiders 115.76%
% held by institutions 149.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 316 Nov 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021


Profit margin 32.93%
Operating margin (ttm)30.81%

Management effectiveness

Return on assets (ttm)5.43%
Return on equity (ttm)13.09%

Income statement

Revenue (ttm)10.29B
Revenue per share (ttm)2.46
Quarterly revenue growth (yoy)60.40%
Gross profit (ttm)4.8B
Net income avi to common (ttm)3.39B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)62.30%

Balance sheet

Total cash (mrq)11.13B
Total cash per share (mrq)2.63
Total debt (mrq)4.3B
Total debt/equity (mrq)13.13
Current ratio (mrq)2.37
Book value per share (mrq)7.64

Cash flow statement

Operating cash flow (ttm)3.43B
Levered free cash flow (ttm)-3.72B